SpaceX Slips 3%, Rocket Lab Sinks 9%, AST SpaceMobile Drops 7% Even as Six Members of Congress Buy SPCX Stock
SpaceX (NASDAQ:SPCX) shares fell about 3% to $109.96 after its June 12 IPO, extending a roughly 30% slide. Rocket Lab (NASDAQ:RKLB) dropped about 9% to $60.63 and AST SpaceMobile (NASDAQ:ASTS) fell about 7% to $54.09 as the Procure Space ETF (NASDAQ:UFO) also declined. Six members of Congress bought SPCX shares totaling $182,000 to $480,000, while Rocket Lab reported a $266 million U.S. Space Force contract and $200.3 million Q1 FY2026 revenue.
How this was made
The 30-second read
Why it matters
Traders are likely to treat this as a flow-driven, catalyst-timed setup: SpaceX faces a near-term lockup supply overhang, while RKLB and ASTS catalysts are being discounted by broad selling and ETF concentration.
Market read
Same-day price action is being driven by sector risk-off and potential SpaceX lockup supply, while company-specific catalysts (contracts and launches) are not yet providing support.
What to watch
The article cites a reported lockup expiration and options positioning, but does not confirm exact mechanics; also, ASTS’s reliance on SpaceX could cut both ways if launch execution improves sentiment into Aug 5.
Background
The piece frames a post-IPO slide in SpaceX alongside sector-wide pressure, while highlighting Rocket Lab’s contract win and ASTS’s upcoming satellite launch.
Ticker impact
SpaceX shares are down 3% and the article flags a reported first lockup expiration around Aug 6 plus Congress buying that is underwater.
Elevated volatility and downside bias into early August unless the lockup passes cleanly.
The text cites a specific lockup window (around Aug 6), options put/call caution, and sustained trading below the $135 IPO price for eight sessions.
Rocket Lab stock is down 9% even after announcing its largest contract ever, a $266 million U.S. Space Force award with options.
Likely choppy to lower near term, with support dependent on whether the sector stabilizes after today’s selloff.
The article pairs a concrete contract award and backlog metrics with a same-day 9% drop and notes theme-wide weakness via the Procure Space ETF.
AST SpaceMobile shares are down 7% despite a planned Aug 5 Falcon 9 launch of BlueBird satellites 11-13 and improved download speeds.
Near-term downside/volatility likely persists until the market sells off less broadly or the launch approaches with renewed buying.
The text explicitly links the 7% drop to a broad sector selloff and highlights that AST relies on SpaceX for launch, adding perceived dependency risk.
RTX is up 20.5% YTD while Rocket Lab and ASTS fall, with Rocket Lab citing Raytheon as a partner in Golden Dome.
Relative outperformance versus pure-play space stocks may continue while sector risk-off persists.
The article provides RTX’s YTD performance and the Raytheon partnership, but it does not disclose a fresh RTX-specific catalyst today.
Iridium is down about 3% as the article reiterates Rocket Lab’s pending $8 billion all-stock acquisition expected to close mid-2027.
Modest volatility around deal headlines, with direction likely tied to broader risk appetite rather than new IRDM-specific news.
The acquisition is described as pending with an expected close date, but the article does not present a new IRDM-specific disclosure.
Market effects
Space names are trading as a high-beta basket, with ETF weakness suggesting flows can overwhelm idiosyncratic contract and launch catalysts.
Primarily US-listed space equities and defense-adjacent exposure, with no explicit regional macro driver beyond broad sector selling.
Space supply-chain and satellite launch cadence sentiment can spill into global satellite and launch-related risk appetite, but the article is US-market focused.
Counterpoint
Congressional buying and Rocket Lab’s contract/backlog could be a contrarian signal that the selloff is overdone, especially if the Aug 6 lockup passes without disruption.
Key entities
- issuerSpaceX
SPCX shares are down 3% and the article flags a reported first lockup expiration around Aug 6.
- issuerRocket Lab
RKLB is down 9% despite a $266 million U.S. Space Force contract and record revenue/backlog metrics.
- issuerAST SpaceMobile
ASTS is down 7% despite an Aug 5 Falcon 9 launch plan for BlueBird satellites 11-13.
- partnerRaytheon
Raytheon is cited as a partner in Rocket Lab’s Golden Dome support statement.
- deal_targetIridium Communications
IRDM is referenced as the target of Rocket Lab’s pending $8 billion all-stock acquisition.
